• Join
  • Login
  • Contact

Search abstracts

Search results for:

697 match(es)

2022 Seville (Spain)

Presentations Invited Speakers (pdf’s of the Powerpoints will be uploaded during the congress)


September 18

Pharmacy in Spain

September 19

No Borderline–Barriers in pharmaceutical care

Plenary: Pharmacy united in recovery of healthcare system (AP1)

Integration of community pharmacy into primary health care: challenges due to COVID 19 and opportunities for the future (A1)

Educational needs and opportunities — Preparing the workforce of the future (A2)

Beyond COVID: Catalysing vaccine technology and drug delivery (A3)

Quality platforms to support hospitals in managing COVID 19: Learnings and opportunities (A4)

It’s not enough to be ethical, we also need to be socially responsible. (A5)

Prospects of innovative pharmaceutical sciences to combat global health challlenges in the future (A6)

Technology Forum: How digital health is changing care delivery for pharmacists and improving public health (LS-M3)

September 20

Plenary: Leading in times of crisis (BP2)

Defining the role of pharmacists in future public health emergencies (B10) (B1)

Equitable access to medicines: managing medicines shortages (B7)

Finding the humanitarian face of pharmacy (B8)

Health technology assessments and rapid access to medicines (B9)

Combatting the mental and behavioural health crisis: the path forward (B11)

New Technologies to enable better care (B12)

Global, regional and national perspectives on the road map ahead for a global action plan in AMR (LS-T2)

No Borderline–Barriers in pharmaceutical care (LS-M2)

Shared experiences and lessons learnt during the pandemic: Preparing for the unexpected (T1)

Shared experiences and lessons learnt during the pandemic: Mental health challenges (T2)

September 21

Plenary: Capturing the breadth and depth of digital health beyond the pandemic (CP3)

Social media and pharmacists’ roles in the infodemic (C13)

Shared decision making: how do we ensure culturally appropriate information and services? (C14)

Are intellectual property rights justifiable in public health emergencies? (C15)

Reinventing primary health care, reinventing pharmacy (C16)

Artificial intelligence in pharmacy practice: Current developments and trends (C17)

The safe handling of new and emerging therapeutics: from mRNA to cell based treatments (C18)

Shared experiences and lessons learnt during the pandemic: Health equity (T3)

Shared experiences and lessons learnt during the pandemic: Expanding horizons (T4)


Academic pharmacy

Clinical biology

Community pharmacy

Drug delivery and manufacturing

Health and medicines information

Hospital pharmacy

Industrial pharmacy

Military and emergency pharmacy

New generation of pharmaceutical scientists

New medicines

Personalised and precision medicine

Pharmacy practice research

Pharmacy technicians

Regulatory sciences and quality

Social and administrative pharmacy


September 19

A high tacrolimus intrapatient variability is associated with adverse kidney transplant outcomes (EPS-02)

An exploratory examination of association of catechol-O-methyltransferase gene variants and neonatal abstinence syndrome outcomes (EPS-11)

Effect of dual trigger on pregnancy outcome in patients with ovarian hyperresponse in GnRH antagonist protocol (EPS-03)

Effectiveness of hospital pharmacist interventions for COPD patients: a systematic literature review (EPS-09)

Exploration and practice of doctor-pharmacist cooperation in antimicrobial therapy for gynecologic oncology patients after surgery (EPS-10)

Medication use evaluation: Ceftazidime-Avibactam combination therapy compared to Ceftazidime-Avibactam monotherapy (EPS-01)

Novel tyrosine kinase inhibitor sulfatinib for the treatment of neuroendocrine neoplasms (EPS-04)

Optimization of medications by pharmacists in the respiratory care ward (EPS-08)

Pharmacy practice of pain management and perioperative nausea and vomiting in thoracic surgery (EPS-05)

Prevalence of pethidine prescriptions in Taiwan(2008–2018) (EPS-12)

The result of medication related problems evaluated by pharmacists at the Mongolian-Japan Hospital, MNUMS (EPS-07)

The roles of ubiquitin-proteasome system, heat shock protein 70 and regulator of G protein signaling 4 in morphine-induced behavioral sensitization (EPS-06)

Please note that the presentation file is not available yet.
PDF will be available to FIP members and congress participants.

Last update 4 October 2019

FIP Congresses